SEC Tracker
Get the app

SAB Biotherapeutics SABS

SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Reports an executive or board change (5.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when SAB Biotherapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. XBiotech XBIT public float $77M, Jun 30, 2025
  2. Oramed Pharmaceuticals ORMP public float $78M, Jun 30, 2025
  3. Inovio Pharmaceuticals INO public float $74M, Jun 30, 2025
  4. Macrogenics MGNX public float $74M, Jun 30, 2025
  5. Volitionrx VNRX public float $73M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.